Enhanced interleukin-4 expression in patients with endometriosis

Fertility and Sterility

Volumn 67, Issue 6, 1997, Pages 1059-1064

  Hsu, Chao Chin ^a   Yang, Bei Chang ^a   Wu, Meng Hsing ^a   Huang, Ko En ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Cytokines; Endometriosis; Interleukin 4; T helper cells type 1; T helper cells type 2

Indexed keywords

DANAZOL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LAPAROSCOPY; MONOCYTE; PERITONEAL FLUID; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030947243     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81439-2     Document Type: Article

References (25)

1. Dmowski WP. Current concepts in the management of endometriosis. Obstet Gynecol Annu 1981; 10:279-311.
2. Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927; 14:422-69.
3. Bartosik D, Jacobs SL, Kelly LJ. Endometrial tissue in peritoneal fluid. Fertil Steril 1986;46:796-800.
4. Dmowski WP, Steele RW, Baker GF. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 1981; 141:377-83.
5. Oosterlynck DJ, Meuleman C, Waer M, Vandeputte M, Koninckx PR. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 1992;58:292-5.
6. Vigano P, Vercellini P, Di Blasio AM, Colombo A, Candiani GB, Vignali M. Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis. Fertil Steril 1991;56:894-9.
7. El-Roeiy A, Dmowski WP, Gleicher N, Radwanska E, Harlow L, Binor Z, et al. Danazol but not gonadotropin-releasing hormone agonist suppresses autoantibodies in endometriosis. Fertil Steril 1988;50:864-71.
8. Koyama N, Matsuura K, Okamura H. Cytokines in the peritoneal fluid of patients with endometriosis. Int J Gynaecol Obstet 1993;43:45-50.
9. Braun DP, Gebel H, House R, Rana N, Dmowski WP. Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis. Fertil Steril 1996; 65:1125-9.
10. Fakih H, Baggett B, Holtz G, Tsang K-Y, Lee JC, Williamson HO. Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril 1987;47:213-7.
11. Mori H, Sawairi M, Nakagawa M, Itoh N, Wada K, Tamaya T. Expression of interleukin-1 (IL-1) beta messenger ribonucleic acid (mRNA) and IL-1 receptor antagonist mRNA in peritoneal macrophages from patients with endometriosis. Fertil Steril 1992;57:535-42.
12. Halme J. Release of tumor necrosis factor-alpha by human peritoneal macrophages in vivo and in vitro. Am J Obstet Gynecol 1989; 161:1718-25.
13. Rier SE, Zarmakoupis PN, Hu X, Becker JL. Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. J Clin Endocrinol Metab 1995; 80:1431-7.
14. Mosmann TR, Coffman RL. TH1 and TH2 cells: different pattern of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
15. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insight. Immunol Today 1994; 15:575-81.
16. American Fertility Society. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril 1985; 43:351-2.
17. Miossec P, Banchereau J. Interleukin 4: a potential antitumor and antiinflammatory agent. In: Oppenheim J, Rossio JL, Gearing AJH, editors. Clinical applications of cytokines. Oxford: Oxford University Press, 1993:171-6.
18. Paul WE. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991; 77:1859-70.
19. Mangan DF, Robertson B, Wahl SM. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol 1992; 148:1812-6.
20. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP, Rugiu FS, et al. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human TH1 and TH2 clones. J Immunol 1992; 148:2142-7.
21. Brooks B, Parry H, Lawry J, Rees R. Evidence that interleukin-4 suppression of lymphokine-activated killer cell induction is mediated through monocytes. Immunology 1992;75: 343-8.
22. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. IL-4 down regulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989; 142:3857-61.
23. Vannier E, Miller LC, Dinarello CA. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992;89:4076-80.
24. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-22.
25. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vires JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.